Bacterial lung infections in cystic fibrosis patients: An update

Pediatric Infectious Disease Journal

Volumn 33, Issue 6, 2014, Pages 653-654

  Chiappini, Elena ^a   Taccetti, Giovanni ^a   De Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM LYSINE; BETA LACTAM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIMETHATE; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TICARCILLIN; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC THERAPY; ATYPICAL MYCOBACTERIUM; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA COMPLEX; CYSTIC FIBROSIS; HUMAN; LUNG INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RALSTONIA; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

BACTERIAL INFECTIONS; BURKHOLDERIA CEPACIA COMPLEX; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA;

EID: 84901480958     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000347     Document Type: Review

References (10)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry. 2011 Annual Data Report. Available at http://www.cff.org/UploadedFiles/research/ ClinicalResearch/2011-Patient-Registry.pdf. Accessed August 20 2013.
2. Döring G Flume P Heijerman H et al.; Consensus Study Group. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012; 11:461-479.
3. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23:299-323.
4. Spicuzza L Sciuto C Vitaliti G et al. Emerging pathogen s in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur J Clin Microbiol Infect Dis. 2009;28:191-195.
5. Taccetti G Bianchini E Cariani L et al.; Italian Group for P. aerugi nosa Eradication in Cystic Fibrosis. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax. 2012;67:853-859.
6. Horsley A Jones AM. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev. 2012;10:CD009529.
7. Wang M Ridderberg W Hansen CR et al. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J Cyst Fibros. 2013;12:638-643.
8. Hansen CR. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen. Curr Opin Pulm Med. 2012;18:628-631.
9. Southern KW Barker PM Solis-Moya A et al. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2012;11:CD002203.
10. Waters V Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis Cochrane Database Syst Rev. 2012 12:CD010004.